Belluscura (FRA:9VQ) Pre-Tax Income : €-9.31 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Belluscura Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Belluscura's pretax income for the six months ended in Jun. 2023 was €-5.93 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was €-9.31 Mil. Belluscura's pretax margin was -1,752.96%.

During the past 5 years, Belluscura's highest Pretax Margin was -583.10%. The lowest was -1240.51%. And the median was -905.11%.

Belluscura Pre-Tax Income Historical Data

The historical data trend for Belluscura's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Pre-Tax Income Chart

Belluscura Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Pre-Tax Income

-1.30

-1.40

-1.63

-4.61

-7.70

Belluscura Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Pre-Tax Income	Get a 7-Day Free Trial				-2.03	-2.45	-4.32	-3.38	-5.93

Competitive Comparison of Belluscura's Pre-Tax Income

For the Medical Devices subindustry, Belluscura's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Belluscura's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Belluscura's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Belluscura's Pre-Tax Income falls into.

Belluscura Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Belluscura's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-9.815	+	0	+	-0.023	+	0	+	2.142
	=	-7.70

Belluscura's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-3.598	+	0	+	-0.209	+	0	+	-2.118
	=	-5.93

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-9.31 Mil.

Belluscura (FRA:9VQ) Pre-Tax Income Explanation

Belluscura's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-5.925	/	0.338
	=	-1,752.96%

During the past 5 years, Belluscura's highest Pretax Margin was -583.10%. The lowest was -1240.51%. And the median was -905.11%.

Belluscura Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Belluscura's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura (FRA:9VQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

BELL:UK

Address

15 Fetter Lane, Holborn, London, GBR, EC4A 1BW

Website

https://www.belluscura.com

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines